(Q24242504)

English

Bradykinin beta-2 receptor antagonists for acute traumatic brain injury

scientific article

In more languages

edit

Statements

0 references

0 references

1 reference

Europe PubMed Central

title

Bradykinin beta-2 receptor antagonists for acute traumatic brain injury (English)

0 references

main subject

brain

0 references

traumatic brain injury

0 references

author

Katharine Ker

series ordinal

1

0 references

author name string

Karen Blackhall

series ordinal

2

0 references

publication date

23 January 2008

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

A single dose, three-arm, placebo-controlled, phase I study of the bradykinin B2 receptor antagonist Anatibant (LF16-0687Ms) in patients with severe traumatic brain injury

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Traumatic brain contusions: a clinical role for the kinin antagonist CP-0127.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

The Epidemiology of Traumatic Brain Injury: A Review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Bradykinin B2 receptor antagonism with LF 18-1505T reduces brain edema and improves neurological outcome after closed head trauma in rats.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Role of activation of bradykinin B2 receptors in disruption of the blood-brain barrier during acute hypertension

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Patients with head injury who talk and die.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

A systematic review of brain injury epidemiology in Europe

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Disability in young people and adults one year after head injury: prospective cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Edema and brain trauma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Primer on medical management of severe brain injury

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Disability in young people and adults after head injury: 5-7 year follow up of a prospective cohort study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD006686.PUB2

retrieved

21 January 2018

Prevention and treatment of secondary brain damage. Clinical aspects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18254109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bradykinin and neuronal injury

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18254109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/14651858.CD006686.PUB2

0 references

PubMed publication ID

18254109

0 references

(Q24242504)

Bradykinin beta-2 receptor antagonists for acute traumatic brain injury

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)